{"schema_version":"secwatch.filing_event.v1","accession":"0001625297-25-000056","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2025-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.511343+00:00","generated_at":"2026-05-17T10:33:54.781964+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Indivior PLC enters new employment agreements with CFO Ryan Preblick; no changes to compensation or role","bullets":["New employment agreement for CFO Ryan Preblick, effective Jan 1, 2025, aligns with current U.S. executive forms.","No changes to compensation, responsibilities, or title from prior 2020 agreement.","Annual base salary remains $558,819; cash bonus target at 60% of base salary (max 120%).","LTIP annual award anticipated at 400% of base salary, subject to Compensation Committee discretion."],"urls":{"canonical":"https://secwatch.observer/filing/0001625297-25-000056","json":"https://secwatch.observer/filing/0001625297-25-000056.json","markdown":"https://secwatch.observer/filing/0001625297-25-000056.md","text":"https://secwatch.observer/filing/0001625297-25-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000162529725000056/0001625297-25-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000162529725000056/indv-20250820.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:33:54.781964+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}